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Summary: The proposal is advanced that anti -cancer drugs generally function by charge
transfer resulting in formation of toxic oxy radicals which destroy the neoplasm. Electrochemical studies were performed with some of the main types of agents: iminium ions (adenine
iminium from alkylating species, iminium metabolite of 6-mercaptopurine, nitidine, other
polynuclear iminiums) and metal complexes (Pt(II)diaquodiammine-guanosine, copper
salicylaldoximes). Reduction potentials ranged from -0.4 to -1.2 V. Literature data for
quinones are presented and radiation is discussed. Based on the theoretical framework, a
rationale is offered for the carcinogen-anti-cancer paradox and the role of antioxidants.

More than two decades ago the oxy radical
for carcinogenesis was advanced
& Guzman Barron, 1951; Holman,
1956; Harman, 1956). Shortly thereafter, the
proposal was placed on a broader, more
systematic foundation (Harman, 1962; Kov. acic, 1959 and 1960). This approach received
scant attention until fairly recent times
which have witnessed ever increasing
support from a variety of disciplines (Ames,
1983; Mason, 1982; Demopoulos et al., 1980).
In general terms, the comprehensive theory
states that oxy radicals are implicated in the
action of most carcinogens, arising as the
end product of metabolic processes, usually
. via charge transfer (CT). Apparently, the
highly reactive radicals subsequently attack
cellular DNA, as well as other crucial
constituents, resulting in transformation to
'. the oncogenic state. Specific application has
· been made to alkylating agents, quinones,
metal complexes, iminium ions .. radiation,
carbon tetrachloride, 4-nitroquinoline 11
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oxide, and inert bodies (Kovacic et al., in
press).
The initial inklings (Holman, 1956; Warburg et al., 1957) that reactive oxy species
may play a role in anti-cancer action was
shortly followed by a better developed,
more comprehensive approach (Kovacic,
1959). A baffling paradox of oncology is the
well-known phenomenon that generally the
substances which induce cancer are also
antineoplastic. If the premise is valid th.at
these agents cause cancer by producing
excessive amounts of oxy radicals, it may
well be that their ability to combat the
condition is intimately related to the same
chemical property. An essential component
of the overall picture is the corollary that
many tumor cells are more susceptible than
normal ones to elevated concentrations of
oxy radicals, thus providing the requisite
specificity. Supporting evidence may be
found from the early days of oncology
(Kovacic, 1959), as well as newer data which
will be presented in the discussion section.
Recently the suggestion was made that
iminium species (1), usually in conjugated
form, play important roles biologically in a

© The Macmillan Press

Ltd, 1986

j<;J

~;;~J

-. ;~r~
198

;;{~

P. KOVACIC et al.

·!'%

. _;-~:;:7

variety of redox transformations (Kovacic,
1984). These entities might then function·
catalytically at the active site as electron
conduits for the formation of superoxide, a
precursor of other oxy radicals (Fridovich,
1983). This concept is now applied to the
anti-cancer domain.
The principal objective of the present
work was to determine the electrochemical
characteristics of several main categories of
antineoplastic agents: iminium ions (adenine iminium from alkylating species, iminium metabolite of 6-mercaptopurine, nitidine, other polynuclear iminiums) and metal
complexes (Pt(II) diaquodiammine-guanosine, copper(II) salicylaldoximes). Literature
data for quinones and other CT agents are
presented, and radiation is discussed. The
results are treated within the context of the
unifying theory for anti-cancer ' action
involving CT with production of toxic oxy
radicals. The carcinogen-anti-cancer paradox is addressed, as well as the role of
antioxidants.

Materials and methods
Isoquinolinium salts 7 and 8 were obtained
from Prof Mark Cushman (Cushman et al.,
1984). Literature methods were used for
synthesis of purine-6-sulfinate 6 (mp 178°C
(dec.), lit. (Doerr et al., 1961); mp 175°C
(dec.), 3-benzyladenine chloride 3 (mp
254-260°C with prior darkening, lit. (Abshire and Berlinquet, 1964; mp 261-267°C),
3-benzyladenine (3-HCl) (mp 268-270°C,
with prior darkening, lit. (Abshire &
Berlinquet, 1964; mp 284-287°C) and 1methyladenosine iodide 4 (mp 190-195°C)
(dec.) Gones & Robins, 1963). Elemental
analyses were satisfactory for the compounds whose melting points differed
appreciably from literature values. Benzothiazoloquinolinium salts 9 (Cox et al., 1982
and unpublished results), and copper(II)
salicylaldoximates 11 (Lumme & Korvola,
1975; Lumme et al., 1984) were prepared as
described. cis- and trans-Oiaquodiammine
platinum(II) nitrates were obtained from the
corresponding OOPs by stirring with two

:~~:~~::~~, !~g~7e~i~g ~h~ lo;ci ~~;cJp~~
0

tate (Marcelis et al., 1980). The solution was
evaporated to dryness in a vacuum over
H 2 S0 4 to yield the product. Complex
formation was attempted (Oehand & Jordanov, 1976) with guanosine and the
cis-diaquo reagent for 30 min, since this Pt
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under vacuum to furnish a solid material.
'"51
Cyclic voltammetry and polarography ·•
were perf0rmed on an ECO model 550 ,
potE~ntiostat with a PARC model 175
waveform generator. All solutions were·.
degassed for 15 min with pre-purified ,
dinitrogen that was passed through an ·~-
oxygen scrubbing system. The working<·
electrodes were a platinum flag or a hanging
mercury drop (HMDE). Reference electrodes<.
were an IBM aqueous Ag/ AgCl or a ,
Corning SCE both in saturated KCI. The <: . .···.,
counter electrode in all cases was a platinum.\'!;:;:(·~
wire. The supporting electrolyte was-;:;·. ·::.•~
tetraethylammonium
perchlorate
(G.F.~.'<;/i•:v,:;;
Smith Chemical Co.). The solvents, N,N.:- .·
dimethylformamide and dimethyl sulfoxide, ·
were obtained from Aldrich Chemical Co. iri.'
the highest possible purity, in addition to;."
cis-OOP, trans-DOP and guanosine hydrate:'·:
Buffer solutions of pH 3.3, 3.9 and 4.8 ··
(HOAc/OAc-) (compound 6) and pH
(50% ETOH/buffer, KHP) (compounds
and 8) were used for cyclic voltammetry.

Results and discussion

Iminium ions
1. Purines
. ,.
(a) Alkylated DNA models: The alkylating:_'
agent class contains a large group of<
antineoplastic agents, including nitro~:)~;
gen mustards, epoxides, aziridines~c'·
triazenes, N-nitroso compounds, and·'
alkyl alkanesulfonates (Reich, 1981). Some_.\
have progressed to the stage of practical~\
use in chemotherapy. As is we11'3
established, the diverse types alsq:r
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generally function as carcinogens (Miller
& Miller, 1983). Concomitant production
of oxy radicals has been observed with
various members (Ames, 1983; Floyd,
1982). Although the precise role of these
reactive intermediates has not been
ascertained, it appears that DNA strand
cleavage may be a crucial event (Floyd,
1982).

12

In a recent investigation of the
mechanism of carcinogenesis, a novel
proposal was advanced in which the salt
form (iminium) of alkylated nucleic acid
was assigned a key function as aCT agent
(Kovacic et al., in press). The purines
(guanine and adenine) of DNA are the
principal targets of attack (Miller and
Miller, 1983). For example, the ionic
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structure 2, a conjugated form of iminium
(1) is generated from 0-6 alkylation of
guanine and could conceivably undergo
one-electron reduction. Electrochemical
data from the literature (Dryhurst, 1977)
and our own studies (Kovacic et al., in
press) are in reasonable accord with the
current picture relating site of alkylation
and defect persistence to oncogenic
response. Thus, it appears quite plausible
that the salt form is functioning in a
catalytic manner as a generator of toxic oxy
radicals.
In order to test this concept as applied
to anti-cancer alkylating agents, salts
derived from alkylation of adenine and
adenosine were investigated electrochemically as models. 3-Benzyladenine
chloride 3 gives irreversible reduction
values of about -1.0 V (Table I). Upon
addition of strong base the potentials
become more negative and the current
drops until, with excess base, there is no
reduction before the background current,
due to generation of the nonreducible,
nonionic base via loss of HCl. Occurrence
of this transformation was confirmed by
electrochemical studies on the free base
which gave no reduction before background. A second model consisted of the
nucleoside with the base alkylated at a
different site, namely, N-1. For 1methyladenosine iodide 4, the most

Table I Cyclic voltammetry of N-alkylated
adeninium and adenosinium halides.a

-Ep
Compound
3-Benzyl adenine
chloride
3-Benzyladenine
1-Methyladenosine
iodide

[OH-] mM DMF DMSO
0.49
0.99
0.49
0.99

0.96
1.03
b

- b
0.96
0.96
- b

1.00
1.19
- b
- b
1.23
1.23
- b

a 100 mV /s, tetraethylammonium perchlorate (0.1 M),
substrate (0.5 mM), Pt electrode, irreversible, vs. SCE.
b No
reduction of substrate before background
reduction.

!1 mA

0.0

-0.5

v

-1.0

Figure 1 Cyclic voltammogram of 4 in DMF, Pt
electrode, scan rate 100mVIs.

positive figure obtained for the reduction
potential was -0.96 V (DMF) (Figure 1,
Table 1). The results were less favorable in
DMSO. The product of the reduction is
probably a dimer, since coupling has been
observed from electrolysis of purine bases
in non-aqueous solvent (Yao et al., 1976).
Our data are in agreement with
previous investigations with adenine in
aqueous acid. E112 values, -1.05 to
-1.07 V, were reported, which varied
. linearly with pH (Dryhurst, 1977).
Adenosine and adenylic acid behaved
similarly. Evidently salt formation oc- ·
curs by preferential protonation at N-1 ·
(Saenger, 1984).
There are several possible sites
adenine alkylation. The preferred one in.
vivo is generally the N-1 position.
Reaction at N-7 is also common!
observed, whereas N-3 attack varies
degree (Shooter, 1972; Rajalakshmi
al., 1982). Alkylation at any of the
positions would produce a potential
agent capable of catalytic operation.
N-3 position has been suggested as
important locale in the carcino
process (Lijinsky, 1976). It is .,J·,F. ... ,,..............
that N-7 adenine salts possess ph
logical activity (Iio et al., 1985).
(b) 6-Mercaptopurine: The properties
_
this drug are summarized in Table Vll.
It, as well as related materials, ·
evidently converted to the corresp
ing nucleotide (Ishiguro et al., 1984)
u

••• (',.,
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the nucleoside (Chabner, 1981; Christie
et al., 1984) followed by insertion into
the DNA chain. The thiol appears to be
oxidized to the unstable sulfenic acid 5
which undergoes further conversion to
the isolable sulfinic acid 6a (Hyslop &
Jardine, 1981; Nelson, 1982). The acids
could exist in an ionic (iminium) form
(cf. 2) either from intra- or intermolecular nuclear protonation.
Since an oxidative metabolite is
thought to be the active agent, we
obtained data on the reduction potential
for 6. In DMF the EP varies from -1.0 V
for the iminium from nuclear protonation to > -2.0 V for the sodium salt (6b)
(Table II). In aqueous buffer 6 exhibits
potentials (V) that vary linearly with pH
(Ep = -0.44-0.100 pH); the most positive value was -0.77 V (pH 3.3). Hence
reduction is facilitated by increasing
acidity. The results in aqueous media
are in agreement with data (V) from an
earlier study (Dryhurst, 1969) in which 6
exhibited E112 = -0.37-0.094 pH (pH 19.1). Reduction involved the N-1=C-6
bond giving the dihydro product (Dryhurst, 1977). Also included were the
parent
thiol,
E112 = -0.79-0.116 pH
(pH 0-5), purine 6-sulfonic acid, E112 =
-0.45-0.078 pH
(pH 1-7),
and
6purinyldisulfide, E112 = -0.0 V. From
these findings Dryhurst concluded that
Table II Cyclic voltammetry
purine-6-sulfinic acid.a

[Acid] mM

HC10 4
HC10 4
HC10 4
HOAc
HOAc
HOAc

0.46
0.91
1.3
pH3.3
pH3.9
pH4.8

H20b

>2.0
1.24
1.03, 1.23
1.00, 1.22

- c
- c

- c
- c

Table III Electrochemistry of fused derivatives of
quinolinium and isoquinolinium salts.a
-EP
Compound
7a

8

9a

9b

d

H20b

-

d

1.09

-

d

d

-

0.99
1.01
1.11
1.24
1.25
1.34
0.39, 1.18
0.42, 1.19
0.65, 1.21
0.42, 1.18
0.45, 1.20
0.66, 1.17

-

1.15
- d
0.89

0.90
1.07

7b

DMSO

DMF

d
d

- d
1.14
d

-

d

1.35
0.42, 1.12
0.45, 1.17
0.64, 1.16
0.45, 1.12
0.47, 1.16
0.67, 1.17

-

d

- d
1.35
- d

-

d

-

d

-

d

-

d

-

d
d

Electrode
techniquec
Hg,P
Pt,CV
Hg,CV
Hg,P
Hg,CV
Pt,CV
Hg,P
Hg,CV
Pt,CV
Hg,P
Hg,CV
Pt,CV
Hg,P
Hg,CV
Pt,CV

a 100mvIS,
tetraethylammonium perchlorate
0.1 M), substrate (0.5 mM), vs. SCE.
b Buffer (KHP) pH 6, no TEAP.
c P-polarography, CV--cyclic voltammetry.
d Not examined electrochemically.

(TEAP,

5 should reduce at a value between
those for 6b and the disulfide.

2. Fused derivatives of quinolinium and isoquinolinium salts.. This class is represented
by the alkaloids nitidine 7a and fagaronine

of

DMF

-

201

c

- c
0.77
0.83
0.92

a 100 mV /s,
tetraethylammonium perchlorate (0.1 M, DMF), 6b (0.5 mM), HMDE
vs. SCE, irreversible.
b HOAc/OAc- buffer.
c Not examined electrochemically.

-0 6

-1 0

-1.4

v
Figure 2 Cyclic voltammogram of 7a in DMF, Pt
electrode, scan rate 100 mV/s.
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7b, the indenoisoquinolinium salt 8 and 3nitrobenzothiazolo(3, 2-a)quinolinium salts
9a, b. Studies on 7 and the analogue 8 gave
values ranging from -0.90 to -1.15 V (Table
III) for 7 and -1.25 to -1.35 V for 8. The
methoxyl .substituent is known to result in
more negative potentials (Zuman, 1967a).
Cyclic voltammetry (CV) (Figure 2) gives
irreversible reductions. On the other hand,
calculations from polarography (P) and CV
indicate reversible behavior. The EP - EP 12
(CV) and E314 - E114 (P) values of 60 mV are in
reasonable agreement with the theoretical
values of 57(CV) and 56(P) mV for a
one-electron process. Isoquinolinium salts
are known to undergo one electron reduction with formation of the 1,1'-dimer
(Bradsher, 1981). The nitrobenzothiazoloquinolinium salts (9a, b) give multiple
reduction values (Table III) (Figure 3); the
most positive range from -0.39 to· _:_0.65 V
(irreversible). The more negative waves,
about -1.2 V, are reversible. Calculations on
the first wave provide values similar to
those from 7, namely, 63(CV) and 60(P) mV.
Apparently the reductions are followed by a
fast follow-up step. There are two predominant electroactive sites associated with 9,
namely, the nitro group and the iminium
ion. The literature E112 for nitrobenzene is
-0.62 V (Wheeler, 1963). Enhancement in
the positive direction in our case is due to a
more extended, electrophilic system of
conjugation. Substitution of methoxyl for
hydrogen in the benzothiazole ring has the
effect of making the reductions more
negative by about 0.03 V as a result of
electron donation, in agreement with the
reported effect of the 4-methoxyl group in

the 1-phenylpyridinium ion, i.e., ~E 112 was
more negative by about 0.03 V (Zuman,
1967a).
The activity of 7 has been correlated with
the presence of the imini urn site (Caolo &
Stermitz, 1979), in keeping with our
theoretical framework. Also N-methylphenanthridinium salts are known to undergo
charge transfer (Parkanyi & Leu, 1975). It is
reasonable to associate the activity of 9 in
part with nitro or the nitroso reduction
product, since compounds of this type are
used in cancer therapy (Docampo &
Moreno, 1984; Murray & Meyn, 1985). These
substances (7-9) may exert their activity by
binding to DNA (Baez et al., 1983; Cushman
et al., 1984). Related anti-tumor alkaloids
include coralyne (Cox et al., 1982) and
sanguinarine (Nandi & Maiti, 1985).
3. Ellipticines. Most members of this class
are anti-tumor agents. Metabolites and
various derivatives incorporate quinoneimine and iminium, e.g., 10. The results
from extensive studies (Paoletti et al., 1983)
are summarized in Table VII. Electrochemical data demonstrate the ability of the
hydroxylated metabolite to function as a
charge transfer entity (Paoletti et al., 1983).
Recent reviews deal with iminium ions
in the alkaloid category (Knabe, 1979) and
from oxidative metabolism of xenobiotics
(Overton et al., 1985). The iminium charge
transfer theory appears broadly applicable
to a wide variety of biologically active
agents (Kovacic, 1984), carcinogens (Kovacic
et al., in press), drugs (quinoxaline-di-Noxides) (Ryan et al., 1985), MPTP (Ames et
al., in press a), phencyclidine, nicotine and
spermine metabolites (Ames et al., in press
b), antimalarials (Ames et al., 1985c),
mesoionic betaines (Ames et al., 1986d) and
benzodiazepines (Crawford et al., in press).

Metal complexes
0.0

-0.5

v

-1 0

-1.5

Figure 3 Cyclic voltammogram of 9a in DMF, Pt
electrode, scan rate 100mVIs.

Metal species are known to elicit a variety of
physiological responses. Specific chemical
reactions that have been observed include
oxygen radical formation (Ames, 1983;·
Stern, 1985) and DNA strand cleavage (Furst
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& Radding, 1984) (Table VII). Formation of
complexes with DNA is reported for some
cases (Furst & Radding, 1984; Saenger, 1984)
(Table VII).

1. cis-DDP. The most prominent member
of the anti-cancer group is cis-DDP. Several
reviews summarize much of the work
(Roberts & Thomson, 1979; Rosenberg, 1980;
& Lippard, 1980). Binding of Pt(II) to
F.--·-~···~·- of DNA is known to occur, and is
to have marked biochemical and
:~¥~:~:\ 'pharmacological significance (Pinto & Lip;z~i·'~:,._pard, 1985; ·Macquet & Theophanides, 1975;
·;,;(~J~~, Ciccarelli et al., 1985). Considerable effort
~&~l;}{ has been devoted to structural analysis of
t:[(: the DNA-Pt(II) complex (Sherman et al.,
· :· 1985; Marcelis et al., 1980; Rosenberg, 1980).
~;~~;:;::
Since there is apparent conversion to the
~~z,~,· diaquodiammine metabolite in vivo (Carsey
,~~~i:.~ & Boudreaux, 1980), attention was centered
*iK:~.·:. on this form in the electroreduction studies.
:;,:'r:· Guanosine was used as the model ligand.
j~? Cyclic voltammetry data for the Pt com·k• .plexes
are presented in Table IV. All
· reductions are irreversible. No reduction
occurs before background for cis-DDP and
Experiments with the cisPt(II)-guanosine complex
or in solution) revealed approximately
Table IV Cyclic voltammetry of Pt(II)guanosine complexes.a

Compound
cis-DDP
trans-DDP
Guanosine
cis-Pt(II)(H20 )2(NH3)2
cis-Pt(II)(H20 )2(NH3hguanosine
cis-Pt(II)(H20 )2(NH3hguanosine (1: 1 solution)
trans-Pt(II)(H 2 0 )2 (NH3) 2
trans-Pt(II)(H20 )2(NH3)2guanosine
(1: 1 solution)
(1: 2 solution)

NRb.c
NRb.c
NRb.c
0.96
0.96
1.0
1.20
1.45
1.30, 1.60

aPt flag,
tetraethylammonium perchlorate
(0.1 M), substrate (0.5 mM), vs. Ag/AgCl, 100 mV/
s.
b

c

No reduction.
200mV/s.
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the same EP values ( -0.96 to -1.0 V) as for
the Pt(II) precursor. The similar results may
be due to involvement of supporting
electrolyte since added salt is known to alter
the 1:1 Pt(II)(H2 0h(NH 3 h-guanoside complex in solution (Marcelis et al., 1980). No
reduction occurs before background for
trans-DDP, and the corresponding diaquo
derivative is reduced at -1.20 V. The transdiaquodiammine Pt(Il)-guanosine complex
(1: 1 and 1:2 in solution) gave EP values
that are more negative ( -1.3 to -1.6 V).
Thus, the reduction potentials in the cis
series are more positive than for the trans
counterparts. Since trans-DDP is less active
(Cleare, 1974) than the cis-isomer a correlation exists between potency and ease of
electroreduction, in accord with the general
mechanistic theme. Prior rationale for the
difference in activity has been summarized
Qohnson et al., 1985).
The proposed pathway entailing catalytic
production of oxy radicals is consistent with
effectiveness of the Pt drug at low doses
(Rosen~erg, 1980; Barton & Lippard, 1980).
The toxicity is reduced by mercaptocontaining compounds that are well known
antioxidants (Nagy et al., 1986; Kempf et al.,
1986). Other radical scavengers such as
a-tocopherol and N,N' -diphenyl-p-phenylenediamine exerted a similar effect (Sugihara
& Gemba, 1986). The investigators proposed
free radical damage by the drug. Also thiols
protected against mutagenesis (Nagy et al.,
1986) a condition generally attributed to oxy
radicals (Kovacic, 1984). There is evidence
for a close relationship between mutagenesis and carcinogenesis (Slaga, 1983). Chromosomal aberrations, primarily chromatid
breaks, are known to be induced by
cis-DDP (Flessel et al., 1980).
2. Complexes of copper and iron
(a) Copper: Some copper complexes in this
category 11 incorporate salicylaldoximes
as chelating agents (Lumme et al., 1984).
Reduction potentials for 11a and 11b
ranged from -0.86 to -0.96 V for the
most positive values with Pt as the
working el~ctrode, and from -0.71 to
-0.86 V with Hg. All of the reductions
were irreversible (Table V) (Figure 4).

P. KOVACIC et al.
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Table V Cyclic voltarnrnetry
salicylaldoxirne complexes. a

Compound
lla
llb

DMF
0.86, 1.29
0.75, 1.23
0.91, 1.26
0.86b

DMSO

of

copper(II)

Electrode

0.93, 1.34
0.71, 1.18
0.97, 1.38
0.84b, 1.28

Pt
Hg
Pt
Hg

a 100 mV /s,
tetraethylammonium perchlorate (0.1 M),
substrate (0.5 mM), irreversible, vs. SCE.
b Reduction with adsorption.

The difference in reduction potential for
lla and llb ( -0.04 to -0.05 V, Pt
electrode) is in agreement with the
reported effect of the hydroxyl group in
anthrone, i.e., ~E 112 was more negative
by 0.01 to 0.05 V (Zuman, 1967b). There
has been a prior suggestion that
electron transfer may play a mechanistic
role in vivo (Lumme & Elo, 1985). For
the
related
Cu(II)(3,5-diisopropylsalicylateh, evidence was provided to
support the contention that hydrogen
peroxide is partly involved in the
anti-tumor action (Oberley et al., 1983).
Another class of copper(II) coordination compounds, the thiosemicarbazones, is known to possess anticancer activity (Petering, 1980; Scovill et
al., 1982). Reduction of the complex
derived from 2-acetylpyridine thiosemicarbazone occurs reversibly at about
-0.5 V (Ames et al., 1985c). The

-0.4

-1.0

v

-1.3

Figure 4 Cyclic voltarnrnograrn of lla, in DMF,
Pt electrode, scan rate 100 rn VIs.

related bis(thiosemicarbazone) complexes display E112 values of -0.34 to
-0.53 V, adjusted to SCE that are
attributed to the reduction of Cu(II) to
Cu(I) (Winkelmann et al., 1974).
According to our guiding theme, there
is CT resulting in toxic oxy radicals via
superoxide. Experimental support is
provided by the observation that
Cu(l)bis(thiosemicarbazone) is autoxidizable by oxygen (Petering, 1972), a
process expected to produce superoxide.
It is relevant that interaction of
heterocyclic carboxaldehyde thiosemicarbazones with DNA was observed to
result in single strand cleavage (Tsiftsoglou et al., 1975); preliminary association of the drug with metal may well
occur. DNA scission is commonly
associated with oxy radical formation
(Demopoulos et al., 1980). Agrawal &
Sartorelli (1978) proposed that the action
on DNA is of major significance for
cytotoxicity.
(b) Iron: Iron complexes of thiosemicarbazones show antineoplastic activity (Scovill et al., 1982). Compound 12 exhibits
a reduction wave at -0.23 V (reversible)
(Ames et al., 1985c).
Proposals have been made that
several well-known agents function
after initial coordination with metal ion.
The action of bleomycin is summarized
in Table VII (Halliwell & Gutteridge,
1985a). According to current thinking
(Hecht, 1979; Lown, 1982), the drug
sequesters Fe(III) in the cell nucleus and
intercalates or binds to DNA. Redox
reactions involving the iron and oxygen
take place. The reduction potential for
the Fe(III) complex is -0.11 V adjusted
to SCE (Melnyk et al., 1981).
Adriamycin is known to be a chelating agent for a number of metal ions
including Fe(II), Fe(III) and Cu(II)
(Halliwell & Gutteridge, 1985a). The
iron complexes bind to DNA (Gianni et
al., 1985) and reduce molecular oxygen·
to reactive radicals. DNA cleavage is
observed.
3. Others.

Various other metals, e.g. Rh,
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;-'Ru, Sn, Ti, V and Mo, in derivative form
>;exhibit anti-cancer activity (Cleare, 1974;
'1> Cleare & Hydes, 1980; Sadler, 1982).
,. ;'However, compared to cis-DDP, they have
-received relatively little attention. In addition, several agents, such as, a,a' -dipyridyl
. ·(Hellman et al., 1983) and picolinic acid
, .(Leuthauser et al., 1982), which are effective
;: against neoplasms, may fit into this
··mechanistic category based on their ability
~,~ to bind metals strongly.
. Quinones and iminoquinones

.: Quinone antibiotics have found widespread
application in recent years in the treatment
of malignancy (Mason,' 1982; Lown, 1982;
. 1983; Waring, 1981). Results from extensive
::. 1 studies, which principally involved anthra•"' ::".cyclines, mitomycins, streptonigrin, and
_;••2L:;.saframycins, are summarized in Table VII.
.>The toxicity, found to be oxygen dependent
::<'. (Halliwell & Gutteridge, 1985a), apparently
.,. _results from redox cycling of the quinone.
Initial metabolic reduction to the semiquinone intermediate, which can bind to
DNA (Sinha & Chignell, 1979) evidently is
an essential step (Lown, 1982; Emanuel et
al., 1984). The overall· process has been
designated 'site-specific free-radical' generation (Bachur et al., 1982). Inhibition of
. the rate of DNA scission was observed with
·added catalase, superoxide dismutase and
free radical scavengers (Lown, 1982).
However, adriamycin bound to DNA is
unable to participate in redox reactions

(Youngman et al., 1984). Strand scission can
occur in the absence of binding.
Iminoquinones have not been as extensively studied. Representative members are
5-iminodaunorubicin (Lown et al., 1982),
anthrapyrazoles (Fry et al., 1985), and
actinomycin D (Halliwell & Gutteridge,
1985a; Doroshow, 1983). Relevant characteristics are intercalation, oxy radical formation, DNA cleavage, and oxygen dependency. As in the quinone case, charge
transfer has not been observed after
intercalation (Emanuel et al., 1984; Sengupta
et al., 1985). Evidence shows that redox
cycling and radical generation are less facile
with the imine analogues (Lown et al.,
1979). Several other anti-cancer agents, e.g.,
rhodamine 123 (Lampidis et al., 1983), and
an oxidative metabolite of ellipticine
(Paoletti et al., 1983), possess similar
structures .
Table VI contains the reduction potentials
for a number of substances in this general
category. The E112 values fall in the range,
-0.20 to -1.09 V. A study revealed that the
anti-tumor activity of 75% of the investigated iminobenzoquinones could be
correctly classified based only on their
reduction potentials (Hodnett et al., 1978).
Also, the iminoquinones, which exhibit
more negative reduction potentials than the
quinones, were found to induce less DNA
strand cleavage (Lown et (ll., 1982). The end
product of anthrapyrazole reduction is the
corresponding dihydro form (Showalter et
al., 1986).

Table VI Reduction potentials for some physiologically active
quinones and iminoquinones.
Compound
Daunorubicin
Adriamycin
Mitomycin B
Mitomycin C
5-Iminodaunorubicin
Anthrapyrazoles
Actinomycin D
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Reduction
potential (V)

Reference
et
et
et
et

al.,
al.,
al.,
al.,

-0.62
-0.62
-0.20
-0.37

Rao
Rao
Rao
Rao

-0.70
-0.98 to -1.09
-0.82

Lown ·et al., 1982
Showalter et al., 1986
Nakazawa et al., 1985

1978
1978
1977a
1977b

206

P. KOVACIC et al.
Table VII

Characteristics of anti-cancer agents.a

Agent

Generation of
reactive
oxygen species

Quinones
Metals
Bleomycin
Ionizing radiation
6-Mercaptopurine
Alkylating agents
Ellipticined
a
b

c
d

DNA
bindingb

DNA
cleavage

+
+
+
+

·+
+
+

+
+

+
+

+
+
+
+
+
+
+

+c

See the discussion for references.
Intercalation or covalent.
Nucleotide insertion.
And derivatives.

The exact state in which these compounds
generate oxy radicals at the active site is not
established with certainty. Alternatively, the
ultimate agent may be a metal complex (vide
supra).

Radiation
Relevant biological effects are summarized
in Table VII (Harman, 1962; Henriksen et
al., 1976; Greenstock & Whitehouse, 1984). It
is conceivable that indirect generation of
oxy radicals also occurs. The nucleic acid
bases are considerably more sensitive than
the phosphate backbone to radiation (Greenstock & Whitehouse, 1984). Purines are
known to form N -oxy species readily on
exposure to peroxide (Robins, 1967), which
might then serve as CT precursors for
radicals (Kovacic et al., in press). For
example, adenine 1-oxide displays an E112 of
-0.81 V, pH 1 (Dryhurst, 1977). Also, some
forms of ionizing radiation apparently give
rise to cationic species that alkylate cellular
constituents (Seifter, et al., 1984).
Correlation of reduction potential with
physiological activity is not new. Examples
include anti-cancer agents (Murray & Meyn,
1985) and other categories (Hodnett et al.,
1978; Bogatskii et al., 1971).
There are indications from prior reports
that reduction potential in vivo may well be
more favorable than in vitro (Kaye &
Stonehill, 1952; Neta et al., 1985), Both dioxidine (E 112 = -1.06 V) (Ryan et al., 1985) and

1-methyl-4-phenylpyridinium ion (cyperquat, MPTP metabolite) E112 = -1.09 V)
(Ames et al., in press, a) which display
rather negative values are reported to
function by oxy radical generation via CT
(Ryan et al., 1985; (MPTP) Markey et al.,
1985). Reversibility is more likely in vivo
due to immobilization of the CT agent at the
active site.

Other considerations
1. Role of oxygen. In our prior discussion,
much evidence has been cited for the
formation and involvement of activated
oxygen species. It is generally believed that
superoxide serves as a precursor. Support
for this standpoint is provided by investigations on the beneficial influence of
oxygen on drug and radiation effectiveness
against cancer cells (Cadenas, 1985; Teicher
et al., 1981; Gupta & Krishan, 1982). The
conclusion was drawn that a common
mechanistic pathway pertains for the
diverse agents (Gupta & Krishan, 1982;
Scheulen · & Kappus, 1984) in accord with
the present thesis. Drug activity observed
during hypoxia (Teicher et al., 1981) can be
rationalized by reductive stress involving
radical processes Gones, 1985).
Free radicals derived from oxygen are
increasingly implicated in the initiation and
progression of various diseases, and in the
toxic action of numerous drugs and chemicals (Nelson, 1982; Holtzman, 1982; Sies,
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1985; Halliwell & Gutteridge, 1985). The
following statement also reflects a unified
approach: 'Several of the chemotherapeutic
agents are thought to have both their
therapeutic and toxic effects by causing an
oxidative stress' (Holtzman, 1982). The
natural phagocytic response to foreign
bodies entails attack by activated oxygen
entities (Baehner et al., 1982).
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obvious relationship between resistance to
ionizing radiation or radical-producing
drugs and tumor cell content of the
following enzymes: Cu-Zn SOD, Mn SOD,
catalase, and glutathione peroxidase (Marklund et al., 1982). These findings of large
variations in the effectiveness of protective
systems may partly account for the observed
differences in response by cancer patients.
Another feature of importance is the rate
of production of superoxide by tumors. If
2. Crucial differences between malignant and
the generation is similar to or greater than
normal cells. As pointed out in the introthe case of normal cells, then the lowered
duction, an important feature of the
levels of protective enzymes in the neocarcinogen-anti-cancer theory is the cancerplasms would result in enhanced sensitivity
cell property of enhanced susceptibility to
to the additional oxidative stress. Investigareactive oxygen-containing entities. This
tors have shown that tumor cell mitochonpostulate, advanced quite some time ago,
dria do produce superoxide (Oberley &
was based primarily on decreased levels of
Buettner, 1979). In one case, the rate of
catalase. Since then, other enzymes which
formation was nearly the same as for normal
destroy these oxy species have been
tissue, whereas in another report there was
discovered and investigated (Willson, 1983).
a five-fold increase.
· The superoxide dismutase (SOD) enzyme
Although chemotherapy and ionizing
. decomposes superoxide which is generated
radiation have proved beneficial in the
by aerobic metabolic reactions. Presumably,
treatment of cancer, relapse and limited
protection is thereby provided from the
applicability are commonly seen (Rosenadverse effects of oxy radicals, such as
berg, 1980). There are a number of possible
hydroxyl, which can arise from the radical
rationalizations (Kovacic, 1959). In the
anion. In fact, various reports reveal
context of the theoretical interpretation,
inhibition of radiation carcinogenesis by
increased concentrations of oxy radicals may
SOD (Hall & Borek, 1983). A considerable
not be completely effective due to the
number of studies have found decreased
survival of a small fraction of resistant
levels of SOD in malignant neoplastic
cancer cells which then proliferate. This is
tissues (Oberley & Buettner, 1979). Mn SOD
reminiscent of the scenario which has been
lower in all cases vs. normal cells. The
encountered repeatedly with drugs, inCu-Zn SOD levels were diminished in
secticides, and herbicides. Furthermore, a
many, but not all, tumors. Glutathione
fine balance would pertain since the radicals
.peroxidase has also been the object of
which are generated to combat malignancy
. attention. The basic premise (Kovacic, 1959)
are also capable of inducing the same
advanced more than 26 years ago has been
condition. Several recent studies are in
confirmed (Alexander, 1983) and restated
harmony with the dual role concept. For
after the discovery of the protective role of
instance, the incidence of second cancers in
SOD: 'If equal amounts of superoxide can
an individual was increased after treatment
be delivered to both cancer cells and normal
then the cancer cell should be
of the primary ones with anti-cancer drugs
killed because it has lower
(Huang et al., 1983). The induction of new
neoplasms was observed as a delayed effect
Indeed, there is evidence
(Harris, 1979). By the same token, initiation
that many of
existing cancer treatments
.,.•., ····"·'x .•.•..·.actually are using this rationale because
of cancer should entail a certain degree of
simultaneous inhibition. In fact, early
many of the anti-cancer drugs have been
investigators have reported precisely this
shown to produce superoxide' (Oberley &
Buettner, 1979). However, other intype of refractory condition on application
vestigators have failed to observe any • of carcinogens (Kovacic, 1959).
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3. Alternate mechanisms. Although the oxy
radical theory possesses many attractive
features, clearly it presents an oversimplified picture of a complex phenomenon. A number of investigations reveal the
important involvement of other factors,
principally immunological reactions, inhibition of DNA synthesis, antimetabolite
action, and DNA defect repair (Rosenberg,
1980; Roberts & Thomson, 1979; Halliwell &
Gutteridge, 1985a; Lumme et al., 1984;
Paoletti et al., 1983; Cushman et al., 1984;
Baez et al., 1983; Doerr et al., 1961; Remy et
al., 1984; Ciccarelli et al., 1985). Specific
examples of compounds that are generally
believed to operate by other routes are
methotrexate (antifolate) (Cole, 1970), adifluoromethylomithine (DFMO, ornithine
decarboxylase inhibitor) (Metcalf et al.,
1978) and 5-fluorouracil (antipyrimidine)
(Cole, 1970). It is noteworthy that evidence
suggests the possibility of CT in some cases.
For instance, conjugated iminium species
derived from pyridoxal phosphate have
been designated as intermediates in the
reaction of DFMO with the enzyme (Metcalf
et al., 1978). From X-ray data on the binary
complex, N-1 protonation of the- pteridine
portion of methotrexate to iminium is
invoked (Bolin et al., 1982). From a study of
the ternary. complex, the drug and NADPH
were shown to be in close proximity
(Matthews et al. 1978). NADPH might be
oxidized by various routes including radical
or CT mechanisms (Filman et al., 1982). A
metal complex may also participate (Kovacic, 1984) in the case of the pyridoxal imine
from DFMO. It is conceivable that several
mechanisms operate in concert for certain
agents. A recent unifying approach for
antineoplastic agents entailed modification
of DNA (Hemminki and Ludlum, 1984).
4. Other biological activity. In addition to
the anti-tumor property, the various agents
can display other physiological activities;
carcinogenic, mutagenic, cytotoxic, and
teratogenic (Magee, 1982; Johnson et al.,
1980; Miller & Miller, 1983; Furst &
Radding, 1984; Fry, 1983). There is a
relationship between antineoplastic activity
and the ability to function as drugs in other

areas (Kinnamon et al., 1980). Perhaps some
of these responses are also due to oxy
radical formation via CT.
5. Role of antioxidants. In prior sections,
the approach entailed treatment of an
established tumor. Alternatively, the problem can be attacked via prevention of
initiation by decreasing the concentration of
oxy intermediates. Anti-cancer agents in
this category, which act as inhibitors of
carcinogenesis, would generally be labeled
as antioxidants (Demopoulos et al., 1980;
Ts'o et al., 1977). A good deal of the work
has involved phenolic types, such as
butylated hydroxyanisole, selenium compounds, vitamin E, vitamin C, and
ethoxyquin. These substances are expected
to be ineffective against existing neoplasms,
and would act only to inhibit the formation
of additional ones from normal cells.
Here again, it is essential to bear in mind
the element of specificity. To be effective the
antioxidant must reach the site at which the
harmful radicals are being generated.
Various characteristics of the protective
agent would come to bear, including
hydrophobic and hydrophilic properies.
Hence, it is not surprising that many
studies reveal beneficial effects of antioxidants, whereas others (Willet et al., 1984)
do not.
In conclusion, the theoretical scheme
entails several features common to most
anti-cancer agents:
1. Binding to DNA by alkylation, complexation (minor groove), intercalation, or
incorporation within the chain as a
special purine.
2. Presence of a charge transfer entity in the
form of an iminium salt, metal complex,
quinone, ArN0 2 or ArNO.
3. Formation of toxic oxy radicals via
superoxide
generated
by
electron
transfer.
4. Attack of vital cellular constituents by
oxy radicals resulting in death of the
cancer.
The carcinogen-anti -cancer paradox is rationalized on the basis of similar mechanisms
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operating in both cases; many tumor cells
are more susceptible than normal ones to
the toxic effects of oxy radicals. Antioxidants
appear to function by destroying harmful
oxy species.
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